Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Neuroprotection in cerebral ischemia by inhibition of the interleukin-1 system: involvement of age-dependent central and peripheral inflammation

FY 2009-10

Summary
Stroke is a major health problem, being the third leading cause of death in Canada. About 15% of stroke patients will die and 75% will suffer from long-lasting disabilities, requiring constant medical support and putting a huge strain on their families with important associate cost on the economy. Stroke occurs during any period of development, from neonate to the adult, but the cellular and molecular mechanisms leading to brain damage differ depending on age. New treatments for stroke are therefore urgently required but, in order to successfully treat all ages, it is necessary to understand the differences between neonatal and adult brain response after a stroke. Both central and peripheral inflammation, and especially the pro-inflammatory and neurotoxic mediator interleukin-1, plays a crucial role in brain damage induced by a stroke. We hypothesize that interleukin-1 is a central player in brain damage after a stroke in both neonates and adults, and we will study the neuroprotective potential of systemically administered new interleukin-1 blockers. This study will enable a better understanding of the central and peripheral mechanisms underlying brain damage after a stroke, especially the differences between neonates and adult responses, and will highlight new age-dependent processes that could be targeted to develop new therapeutic strategies.
Program
CIHR Fellowship
Location
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
203040
Name
Girard Sylvie
Country
United Kingdom
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Neuroprotection in cerebral ischemia by inhibition of the interleukin-1 system: involvement of age-dependent central and peripheral inflammation
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Animal Models; Behavioural Analysis; Cerebral Ischemia; Cytokines; In Vivo Imaging; Inflammation; Neuroprotection; Stroke
Abstract
Stroke is a major health problem, being the third leading cause of death in Canada. About 15% of stroke patients will die and 75% will suffer from long-lasting disabilities, requiring constant medical support and putting a huge strain on their families with important associate cost on the economy. Stroke occurs during any period of development, from neonate to the adult, but the cellular and molecular mechanisms leading to brain damage differ depending on age. New treatments for stroke are therefore urgently required but, in order to successfully treat all ages, it is necessary to understand the differences between neonatal and adult brain response after a stroke. Both central and peripheral inflammation, and especially the pro-inflammatory and neurotoxic mediator interleukin-1, plays a crucial role in brain damage induced by a stroke. We hypothesize that interleukin-1 is a central player in brain damage after a stroke in both neonates and adults, and we will study the neuroprotective potential of systemically administered new interleukin-1 blockers. This study will enable a better understanding of the central and peripheral mechanisms underlying brain damage after a stroke, especially the differences between neonates and adult responses, and will highlight new age-dependent processes that could be targeted to develop new therapeutic strategies.
Competitiondate
201002
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Girard, Sylvie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
Direct Payment - $150,000 Grant (2009-10) | Canada Spends